1. Home
  2. RCKT vs MATW Comparison

RCKT vs MATW Comparison

Compare RCKT & MATW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • MATW
  • Stock Information
  • Founded
  • RCKT 1999
  • MATW 1850
  • Country
  • RCKT United States
  • MATW United States
  • Employees
  • RCKT N/A
  • MATW N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • MATW Metal Fabrications
  • Sector
  • RCKT Health Care
  • MATW Telecommunications
  • Exchange
  • RCKT Nasdaq
  • MATW Nasdaq
  • Market Cap
  • RCKT 764.5M
  • MATW 614.6M
  • IPO Year
  • RCKT N/A
  • MATW 1994
  • Fundamental
  • Price
  • RCKT $6.99
  • MATW $20.41
  • Analyst Decision
  • RCKT Strong Buy
  • MATW Strong Buy
  • Analyst Count
  • RCKT 10
  • MATW 1
  • Target Price
  • RCKT $43.90
  • MATW $40.00
  • AVG Volume (30 Days)
  • RCKT 3.1M
  • MATW 299.3K
  • Earning Date
  • RCKT 05-08-2025
  • MATW 04-30-2025
  • Dividend Yield
  • RCKT N/A
  • MATW 5.04%
  • EPS Growth
  • RCKT N/A
  • MATW N/A
  • EPS
  • RCKT N/A
  • MATW N/A
  • Revenue
  • RCKT N/A
  • MATW $1,703,999,000.00
  • Revenue This Year
  • RCKT N/A
  • MATW N/A
  • Revenue Next Year
  • RCKT N/A
  • MATW $1.87
  • P/E Ratio
  • RCKT N/A
  • MATW N/A
  • Revenue Growth
  • RCKT N/A
  • MATW N/A
  • 52 Week Low
  • RCKT $4.55
  • MATW $18.50
  • 52 Week High
  • RCKT $26.98
  • MATW $32.24
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 48.90
  • MATW 49.45
  • Support Level
  • RCKT $6.21
  • MATW $18.61
  • Resistance Level
  • RCKT $8.26
  • MATW $21.68
  • Average True Range (ATR)
  • RCKT 0.54
  • MATW 0.87
  • MACD
  • RCKT 0.03
  • MATW 0.10
  • Stochastic Oscillator
  • RCKT 38.05
  • MATW 58.63

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

Share on Social Networks: